ORBIMED ADVISORS LLC - Significant Ownership

Signature - Title
Sven H. Borho - Member
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by ORBIMED ADVISORS LLC.

Significant Ownership of ORBIMED ADVISORS LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TRAW Traws Pharma, Inc. Common Stock 19.9% $2.15M 761K ORBIMED ADVISORS LLC Dec 31, 2024
PASG Passage BIO, Inc. Common Stock 12% $4.2M 7.4M ORBIMED ADVISORS LLC Dec 20, 2024
CMPX Compass Therapeutics, Inc. COMMON STOCK 11% $38.2M 15.2M ORBIMED ADVISORS LLC Apr 9, 2024
RAPT RAPT Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.9% $16.4M 13.1M ORBIMED ADVISORS LLC Dec 31, 2024
SION Sionna Therapeutics, Inc. Common Stock 8.4% $63.4M 3.7M ORBIMED ADVISORS LLC Feb 10, 2025
FBRX Forte Biosciences, Inc. Common Stock, par value $0.001 per share 8% $3.06M 510K ORBIMED ADVISORS LLC Dec 31, 2024
CRBP Corbus Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share 5.9% $4.88M 718K OrbiMed Capital LLC Dec 31, 2024
IRON Disc Medicine, Inc. Common Stock 4.5% $83.9M 1.56M ORBIMED ADVISORS LLC Mar 10, 2025
ADCT ADC Therapeutics SA Common Shares, par value CHF 0.08 per share 3.6% $6.08M 3.44M ORBIMED CAPITAL LLC Dec 31, 2024
XTNT Xtant Medical Holdings, Inc. COMMON STOCK 0% $0 0 ORBIMED ADVISORS LLC Apr 10, 2025

Schedules 13D/G Reported by ORBIMED ADVISORS LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.